-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
【Chemical Machinery and Equipment Network Star Enterprise】November 7, 2022, Shanghai - The 5th China International Import Expo (hereinafter referred to as the "Expo") has kicked off
。 Agilent Technologies (NYSE: A) debuted at the Expo for the fourth year, with the theme of "Innovation Without Boundaries", showing all walks of life the results of the continuous and in-depth implementation of localization development strategies in the past year or longer; At the same time, Agilent also brought a range of innovative analytical and testing technologies, products, solutions, and services at its booth (Hall 8.
1, A4-02), showcasing the company's progress
in mature market areas where it excels and emerging areas where it is focusing on it.
All of these achievements and technological innovations selected for exhibition are based on the long-term goal of Chinese-style modernization in the new era and new journey, reflecting the role and value of analytical testing technology in the process of high-quality and sustainable development of the country, which is also a true portrayal
of Agilent's continuous fulfillment of the company's commitment to China for more than 40 years.
。 Agilent Technologies (NYSE: A) debuted at the Expo for the fourth year, with the theme of "Innovation Without Boundaries", showing all walks of life the results of the continuous and in-depth implementation of localization development strategies in the past year or longer; At the same time, Agilent also brought a range of innovative analytical and testing technologies, products, solutions, and services at its booth (Hall 8.
1, A4-02), showcasing the company's progress
in mature market areas where it excels and emerging areas where it is focusing on it.
All of these achievements and technological innovations selected for exhibition are based on the long-term goal of Chinese-style modernization in the new era and new journey, reflecting the role and value of analytical testing technology in the process of high-quality and sustainable development of the country, which is also a true portrayal
of Agilent's continuous fulfillment of the company's commitment to China for more than 40 years.
Liang Chen, Agilent Global Vice President and General Manager of Greater China, said, "We are honored to participate in CIIE
for the fourth time.
In this highly anticipated and significant CIIE, we will use pragmatic and vivid case achievements to interpret the connotation of this year's exhibition theme - 'Boundless Innovation with Ambition', tell all walks of life that we have gone deep into thousands of industries in China, relying on leading analysis and testing technology, and work with all parties to cope with and solve various scientific research challenges; at the same time, we also hope that in the platform full of opportunities, we will collide with all relevant parties to create new sparks, make progress together and shape value
together 。 As the whole country embarks on the journey of the second centenary goal, we are determined to continue to exert leadership in our own fields with the innovative spirit and achievements that are not satisfied with the status quo, and make more new contributions
to the development of Chinese-style modernization.
”
for the fourth time.
In this highly anticipated and significant CIIE, we will use pragmatic and vivid case achievements to interpret the connotation of this year's exhibition theme - 'Boundless Innovation with Ambition', tell all walks of life that we have gone deep into thousands of industries in China, relying on leading analysis and testing technology, and work with all parties to cope with and solve various scientific research challenges; at the same time, we also hope that in the platform full of opportunities, we will collide with all relevant parties to create new sparks, make progress together and shape value
together 。 As the whole country embarks on the journey of the second centenary goal, we are determined to continue to exert leadership in our own fields with the innovative spirit and achievements that are not satisfied with the status quo, and make more new contributions
to the development of Chinese-style modernization.
”
Panoramic view of the Agilent showroom
"In China, for China", continuous investment in the Chinese market is Agilent's "ambition", and it is also a strong foundation
for the company to continue to bear the fruits of localized development.
Over the past year, Agilent localization has continued to bear fruit in several areas and levels, such as:
for the company to continue to bear the fruits of localized development.
Over the past year, Agilent localization has continued to bear fruit in several areas and levels, such as:
• At the beginning of this year (2022), Agilent expanded multiple product lines in the Shanghai manufacturing center, expanding production scale including advanced technology products such as liquid chromatography, spectroscopy, and mass spectrometry, further improving domestic manufacturing capabilities, and providing strong support for the development of emerging national strategic industries such as biomedicine, new materials, and new energy.
• Earlier this year, Agilent helped Sinopec's Research Institute of Petroleum Research to build Sinopec's Xiwanzi Hydrogen Testing Laboratory in Chongli, Hebei Province, which is the first on-site laboratory
for a hydrogen refueling station in China.
The laboratory applies the Agilent PDHID-GC scheme, which can control the concentration of sensitive impurities in hydrogen at the PPB level to ensure the quality of hydrogen for fuel cell vehicles in winter sports events.
for a hydrogen refueling station in China.
The laboratory applies the Agilent PDHID-GC scheme, which can control the concentration of sensitive impurities in hydrogen at the PPB level to ensure the quality of hydrogen for fuel cell vehicles in winter sports events.
• In September this year, Agilent's CrossLab Supply Chain 2.
0 program, the "High-Speed Regional Service Improvement Program", was officially launched, accompanied by the launch of Agilent CrossLab consumables and repair parts front warehouse, Wuhan Parts Warehouse
.
Combined with a new digital consumables procurement model and the complementarity of multiple domestic consumables and maintenance parts warehouses, Agilent has expanded the stocking capacity of domestic consumables and maintenance spare parts in multiple modes to reduce supply chain and logistics risks caused by the pandemic or other factors.
0 program, the "High-Speed Regional Service Improvement Program", was officially launched, accompanied by the launch of Agilent CrossLab consumables and repair parts front warehouse, Wuhan Parts Warehouse
.
Combined with a new digital consumables procurement model and the complementarity of multiple domestic consumables and maintenance parts warehouses, Agilent has expanded the stocking capacity of domestic consumables and maintenance spare parts in multiple modes to reduce supply chain and logistics risks caused by the pandemic or other factors.
• Also at the end of September this year, Agilent's two advanced flow cytometers were approved for marketing, becoming domestic medical devices that can be used for in vitro diagnostics, and are used clinically for multi-parameter quantitative analysis of cells or particles derived from human samples; Previously, in early 2020, Agilent's PD-L1 (22C3) test kit (immunohistochemistry) (PD-L1 IHC 22C3 pharmDx) has been approved by the National Medical Products Administration for the identification of esophageal squamous cell carcinoma (ESCC) patients who can receive KEYTRUDA (pembrolizumab);
• Agilent continues to invest in supporting China's scientific and technological innovation, including supporting Chinese scientists in the field of biology, while building a strong talent base
for China's future innovation.
In 2021, Agilent's scientific research donations to Chinese universities and research institutes exceeded those in 2020; In October this year, Agilent CEO Mike McMullen also announced that he will continue to support scientific and technological innovation projects in China, including awarding the "Agilent Thought Leader Award" to a Chinese scientist in the field of biology, and starting the "Youth Future Science and Technology Innovation Training Program";
for China's future innovation.
In 2021, Agilent's scientific research donations to Chinese universities and research institutes exceeded those in 2020; In October this year, Agilent CEO Mike McMullen also announced that he will continue to support scientific and technological innovation projects in China, including awarding the "Agilent Thought Leader Award" to a Chinese scientist in the field of biology, and starting the "Youth Future Science and Technology Innovation Training Program";
• In addition, over the past year, Agilent has partnered with a number of industry leaders and companies to help them strengthen their competitive advantage in their respective fields with stable and superior technologies to drive the industry forward
.
.
The list goes on, and the accumulation of the past year is inspiring new results
.
Under the background of the state embarking on and focusing on creating a new development pattern of "dual circulation", Agilent's localized development is not ending
.
.
Under the background of the state embarking on and focusing on creating a new development pattern of "dual circulation", Agilent's localized development is not ending
.
Agilent's "Innovation Without Boundaries" is manifested in the company's close cooperation with all parties, continue to explore the needs of modern scientific research laboratories, and use automation, digitalization, intelligent analysis technology and equipment, as well as closely related consumables, services, software, and digital applications, etc.
, to reduce the complexity of instrument equipment and laboratory operation and maintenance operations, and improve the efficiency
of analysis and testing workflows 。 Agilent continues to bring these technological and application-level innovations, allowing researchers to devote their limited time and energy to research, providing trusted answers and in-depth industry insights
to a wide range of research fields and cutting-edge topics.
, to reduce the complexity of instrument equipment and laboratory operation and maintenance operations, and improve the efficiency
of analysis and testing workflows 。 Agilent continues to bring these technological and application-level innovations, allowing researchers to devote their limited time and energy to research, providing trusted answers and in-depth industry insights
to a wide range of research fields and cutting-edge topics.
Agilent set up a live broadcast session of "Agilent Everywhere" at this Expo, leading off-site audiences to enjoy the Agilent booth online and the role of Agilent in the development of important industries at the Expo
At this Expo, Agilent's exhibits are intuitively expressing these innovative ideas - in the field of industrial and chemical analysis that Agilent is good at, the advanced mass spectrometry and gas chromatography displayed by Agilent have long been recognized as the best, they have entered countless domestic enterprise R & D departments and scientific research institutions, covering a wide range of basic research levels from raw material analysis to process control, product research and development, quality control, etc.
, and in the emerging field where the company is focusing on clinical and life sciences, Agilent demonstrated biological liquid chromatography, LC/MS is helping the innovative drug and biopharmaceutical industries accelerate the time
to market.
In addition, a variety of Agilent gene and cell analysis testing instruments on display at the booth are increasingly entering cutting-edge scientific research fields such as genetic testing, pathology, metabolomics, synthetic biology, and cell analysis, helping life science workers and researchers penetrate into the microscopic field of the human body and unlock more health mysteries
.
, and in the emerging field where the company is focusing on clinical and life sciences, Agilent demonstrated biological liquid chromatography, LC/MS is helping the innovative drug and biopharmaceutical industries accelerate the time
to market.
In addition, a variety of Agilent gene and cell analysis testing instruments on display at the booth are increasingly entering cutting-edge scientific research fields such as genetic testing, pathology, metabolomics, synthetic biology, and cell analysis, helping life science workers and researchers penetrate into the microscopic field of the human body and unlock more health mysteries
.
Sustainability is also Agilent's long-term vision and mission, which is consistent with
the country's goal of high-quality, sustainable development.
In line with sustainability, Agilent has announced that it will achieve net-zero greenhouse gas emissions by 2050 and is focusing more on sustainability at the product development level—through a third-party partner, My Green Lab, Agilent is showcasing mass spectrometry, gas phase, and liquid chromatography that has received the organization's Accountability, Conformance, and Transparency (ACT) labels, providing a benchmark and framework for continuously improving the environmental impact of Agilent products; At the level of research and application of sustainability issues, Agilent is also working with several domestic scientific research institutions and enterprises to challenge
the practical application of various clean energy projects, including hydrogen energy, lithium battery, photovoltaic polysilicon, etc.
the country's goal of high-quality, sustainable development.
In line with sustainability, Agilent has announced that it will achieve net-zero greenhouse gas emissions by 2050 and is focusing more on sustainability at the product development level—through a third-party partner, My Green Lab, Agilent is showcasing mass spectrometry, gas phase, and liquid chromatography that has received the organization's Accountability, Conformance, and Transparency (ACT) labels, providing a benchmark and framework for continuously improving the environmental impact of Agilent products; At the level of research and application of sustainability issues, Agilent is also working with several domestic scientific research institutions and enterprises to challenge
the practical application of various clean energy projects, including hydrogen energy, lithium battery, photovoltaic polysilicon, etc.
During this Expo, Agilent also signed cooperation agreements
with many enterprises such as Sinopharm Group and Qilu Pharmaceutical.
with many enterprises such as Sinopharm Group and Qilu Pharmaceutical.
About Agilent Technologies
Agilent Technologies (NYSE: A) is a global player in the life sciences, diagnostics, and applied chemistry markets, providing insight and innovation to help improve quality of life
.
Agilent offers a comprehensive range of instrumentation, software, services, and expertise to provide more reliable answers
to customers' challenging challenges.
In fiscal 2021, Agilent had revenues of $6.
32 billion and 17,000 employees worldwide
.
.
Agilent offers a comprehensive range of instrumentation, software, services, and expertise to provide more reliable answers
to customers' challenging challenges.
In fiscal 2021, Agilent had revenues of $6.
32 billion and 17,000 employees worldwide
.
